PetMed Express (PETS) Stock Analysis & Winston Score

PetMed Express, also known as 1-800-PetMeds, is an online pharmacy that sells prescription and non-prescription pet medications directly to pet owners in the United States. Its main products include flea and tick treatments, heartworm preventatives, and other common pet medicines for dogs and cats. The company competes in the pet health industry, where it was one of the early pioneers of direct-to-consumer pet pharmacy retail.

PetMed Express makes money by selling medications through its website and by phone, earning a margin on each product sold rather than charging subscriptions. It operates entirely within the U.S. and is a small-cap company facing intense competition from large rivals like Chewy, Amazon, and traditional veterinary clinics that have expanded their own online pharmacies. The company's negative operating margin signals it is currently spending more than it earns, and its biggest challenge is retaining customers and growing sales volume in a crowded market where larger competitors have significant pricing and logistics advantages.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-30.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-124.0% YoY

YoY Growth Rate

Earnings declining

Insider Activity

36.6%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$55M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

PetMed Express's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

40.8%

Healthy — 40.8% gross margin

Operating Margin

-13.0%

Losing money on operations — -13.0%

ROCE

-7.0%

Weak — -7.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-26.0%

Shrinking sales (-26.0% YoY)

EPS YoY

-54836.8%

Earnings shrinking (-54836.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-12.5%

Burning cash (-12.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.01

Conservative — low debt load (0.01)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial